Adaptimmune Therapeutics plc (473A) — Tangible Net Worth Ratio
Adaptimmune Therapeutics plc (473A) has a Tangible Net Worth Ratio of 67.3% as of December 2024. This metric is calculated by deducting intangible assets (€3.88 Million) from net assets (€11.85 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Adaptimmune Therapeutics plc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Adaptimmune Therapeutics plc Tangible Net Worth Ratio (2016–2024)
This chart shows how Adaptimmune Therapeutics plc's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of December 2024, the ratio stands at 67.3%, reflecting net assets of €11.85 Million with intangible assets of €3.88 Million EUR. See defensive interval ratio of Adaptimmune Therapeutics plc to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Adaptimmune Therapeutics plc (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Adaptimmune Therapeutics plc from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 473A market cap.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 67.3% | €11.85 Million | €3.88 Million | €245.96 Million | ▼ -31.9 pp |
| 2023 | 99.2% | €39.51 Million | €330.00K | €282.62 Million | ▼ -0.3 pp |
| 2022 | 99.5% | €81.88 Million | €442.00K | €328.92 Million | ▼ -0.1 pp |
| 2021 | 99.5% | €205.96 Million | €1.00 Million | €469.55 Million | ▲ +0.0 pp |
| 2020 | 99.5% | €341.23 Million | €1.73 Million | €451.14 Million | ▲ +1.3 pp |
| 2019 | 98.2% | €123.64 Million | €2.20 Million | €181.54 Million | ▼ -1.2 pp |
| 2018 | 99.4% | €246.88 Million | €1.47 Million | €276.74 Million | ▲ +0.1 pp |
| 2017 | 99.3% | €202.98 Million | €1.34 Million | €281.15 Million | ▲ +0.1 pp |
| 2016 | 99.2% | €166.14 Million | €1.27 Million | €234.51 Million | — |